NASDAQ:CGTX

Cognition Therapeutics Stock Forecast

etoro logo Buy CGTX
*Your capital is at risk
$1.42
+0.0700 (+5.19%)
At Close: Jun 03, 2026
AI Analysis AI Analysis of CGTX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CGTX to Watchlist?
Some Reasons Why To Add CGTX:
  • +361.6% price growth over the last year
  • Bullish trend confirmed on both short and long timeframes
  • Consistently positive technical signals over the last month
PDF

Big movements in Cognition Therapeutics, Inc. stock price on Wednesday moving 13.33% between high and low
(Updated on Jun 03, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy candidate since Jun 01, 2026 Gain 13.60%

The Cognition Therapeutics, Inc. stock price gained 5.19% on the last trading day (Wednesday, 3rd Jun 2026), rising from $1.35 to $1.42. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 13.33% from a day low at $1.28 to a day high of $1.45. The price has risen in 5 of the last 10 days and is up by 27.93% over the past 2 weeks. Volume fell on the last day by -698 thousand shares and in total, 2 million shares were bought and sold for approximately $3.11 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $1.43 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 26.60% during the next 3 months and, with a 90% probability hold a price between $1.02 and $1.81 at the end of this 3-month period.

CGTX Signals & Forecast

Mostly positive signals in the chart today. The Cognition Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $1.26 and $1.22. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, March 30, 2026, and so far it has risen 138.82%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Cognition Therapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.28 and $1.17. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Cognition Therapeutics, Inc. finds support just below today's level at $1.28. If this is broken, then the next support from accumulated volume will be at $1.17 and $1.08.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.170 between high and low, or 13.33%. For the last week, the stock has had daily average volatility of 10.94%.

Our recommended stop-loss: $1.37 (-3.18%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 45 days ago.)

Trading Expectations (CGTX) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect Cognition Therapeutics, Inc. to open at $1.38, and during the day (based on 14 day Average True Range), to move between $1.37 and $1.47, which gives a possible trading interval of +/-$0.107 (+/-7.83%) up or down from last closing price. If Cognition Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 7.83% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $1.28, some $0.140 (9.86%) from the current price of $1.42, our system finds the risk reward attractive.

Is Cognition Therapeutics, Inc. stock A Buy?

Cognition Therapeutics, Inc. holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.

Current score: 7.993 Strong Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $1.38 ( 2.82%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CGTX Performance

Trading levels for CGTX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.55 9.15%
R2 1.49 4.58%
R1 1.44 1.76%
Price 1.42
S1 1.32 -7.39%
S2 1.27 -10.22%
S3 1.21 -14.79%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 1.42
S1 1.28 -9.86%
S2 1.17 -17.61%
S3 1.08 -23.94%

FAQ

What is the symbol for Cognition Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Cognition Therapeutics, Inc. is CGTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Cognition Therapeutics, Inc. Stock?
Cognition Therapeutics, Inc. holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.

How to buy Cognition Therapeutics, Inc. Stock?
Cognition Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cognition Therapeutics, Inc. Stock.

What's the current price of Cognition Therapeutics, Inc. Stock?
As of the end of day on the Jun 03, 2026, the price of an Cognition Therapeutics, Inc. (CGTX) share was $1.42.

What is the 52-week high and low for Cognition Therapeutics, Inc. Stock?
The 52-week high for Cognition Therapeutics, Inc. Stock is $3.83 and the 52-week low is $0.250.

What is the market capitalization of Cognition Therapeutics, Inc. Stock?
As of the Jun 03, 2026, the market capitalization of Cognition Therapeutics, Inc. is 104.487M.

When is the next earnings date for Cognition Therapeutics, Inc.?
The upcoming earnings date for Cognition Therapeutics, Inc. is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT COGNITION THERAPEUTICS, INC.
Cognition Therapeutics
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical trial for the treatment of mild-to-moderate Alzheimer's disease, as well as has completed Phase I clinica...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE